These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3942836)
1. Paroxysmal nocturnal hemoglobinuria erythrocytes are of two distinct types: positive or negative for acetylcholinesterase. Dockter ME; Morrison M Blood; 1986 Feb; 67(2):540-3. PubMed ID: 3942836 [TBL] [Abstract][Full Text] [Related]
2. The acetylcholinesterase defect in paroxysmal nocturnal hemoglobinuria: evidence that the enzyme is absent from the cell membrane. Chow FL; Telen MJ; Rosse WF Blood; 1985 Oct; 66(4):940-5. PubMed ID: 4041621 [TBL] [Abstract][Full Text] [Related]
3. Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria. Chow FL; Hall SE; Rosse WF; Telen MJ Blood; 1986 Apr; 67(4):893-7. PubMed ID: 3955235 [TBL] [Abstract][Full Text] [Related]
4. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis. Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964 [TBL] [Abstract][Full Text] [Related]
5. Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH). A comparison of the complement-sensitive and insensitive populations. Kunstling TR; Rosse WF Blood; 1969 Apr; 33(4):607-16. PubMed ID: 5776206 [No Abstract] [Full Text] [Related]
6. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Nicholson-Weller A; March JP; Rosenfeld SI; Austen KF Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5066-70. PubMed ID: 6576376 [TBL] [Abstract][Full Text] [Related]
8. Acetylcholinesterase and lymphocyte function-associated antigen 3 found on decay-accelerating factor-negative erythrocytes from some patients with paroxysmal nocturnal hemoglobinuria are lost during erythrocyte aging. Ueda E; Kinoshita T; Terasawa T; Shichishima T; Yawata Y; Inoue K; Kitani T Blood; 1990 Feb; 75(3):762-9. PubMed ID: 1688724 [TBL] [Abstract][Full Text] [Related]
9. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes. Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544 [TBL] [Abstract][Full Text] [Related]
10. A case report of paroxysmal nocturnal hemoglobinuria in a child. Higashigawa M; Murata H; Iguchi K; Sakurai M Acta Paediatr Jpn; 1991 Feb; 33(1):99-101. PubMed ID: 1853721 [TBL] [Abstract][Full Text] [Related]
11. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. Parker CJ; Baker PJ; Rosse WF J Clin Invest; 1982 Feb; 69(2):337-46. PubMed ID: 6915939 [TBL] [Abstract][Full Text] [Related]
12. Study of the acetylcholinesterase activity of AET-treated (2-aminoethylisothiouronium bromide) normal red cells (PNH-like cells). Ferrone S; Zanella A; Sirchia G Acta Vitaminol Enzymol; 1970; 24(6):222-5. PubMed ID: 5537936 [No Abstract] [Full Text] [Related]
13. Structural and functional differences between decay-accelerating factor and red cell acetylcholinesterase. Sugarman J; Devine DV; Rosse WF Blood; 1986 Sep; 68(3):680-4. PubMed ID: 2427138 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570 [TBL] [Abstract][Full Text] [Related]
15. The mechanism of decreased red cell acetylcholinesterase activity in patients with paroxysmal nocturnal hemoglobinuria: Its relation to the membrane lipids. Shinohara K; Matsumoto N; Ishida Y; Kaneko T Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):25-9. PubMed ID: 6858569 [No Abstract] [Full Text] [Related]
16. Paroxysmal nocturnal hemoglobinuria (PNH) as a clonal disorder. Hartmann RC; Arnold AB Annu Rev Med; 1977; 28():187-94. PubMed ID: 324358 [TBL] [Abstract][Full Text] [Related]
17. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Hall SE; Rosse WF Blood; 1996 Jun; 87(12):5332-40. PubMed ID: 8652849 [TBL] [Abstract][Full Text] [Related]
18. Two populations of erythroid cell progenitors in paroxysmal nocturnal hemoglobinuria. Rotoli B; Robledo R; Scarpato N; Luzzatto L Blood; 1984 Oct; 64(4):847-51. PubMed ID: 6478058 [TBL] [Abstract][Full Text] [Related]
19. Relation between low erythrocyte acetylcholinesterase activity and membrane lipids in paroxysmal nocturnal haemoglobinuria. Siriwittayakorn J; Yuthavong Y Br J Haematol; 1979 Mar; 41(3):383-91. PubMed ID: 427042 [TBL] [Abstract][Full Text] [Related]
20. The population of paroxysmal nocturnal hemoglobinuria neutrophils deficient in decay-accelerating factor is also deficient in alkaline phosphatase. Burroughs SF; Devine DV; Browne G; Kaplan ME Blood; 1988 Apr; 71(4):1086-9. PubMed ID: 2451546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]